[Featured Stock] Respiratory Therapy Device Company Mecaics Up 26%
Mecics, a company specializing in respiratory therapy devices, is hitting the upper price limit.
At 10:35 AM on the 24th, Mecics is trading at 4,535 KRW, up 26.32% compared to the previous day.
This is interpreted as being influenced by the resurgence of COVID-19 in China. On the 22nd, local Chinese media reported that Chinese epidemic prevention experts predicted the peak of the second COVID-19 wave would occur by the end of next month.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Mecics is a specialized company in ventilators and respiratory therapy devices. As of the end of January, it supplied 700 units of the respiratory therapy drug HFT500 to China.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
